Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

140.46
Delayed Data
As of 3:59pm ET
 +0.22 / +0.16%
Today’s Change
96.18
Today|||52-Week Range
149.34
+14.80%
Year-to-Date

Today’s Trading

Previous close140.24
Today’s open140.04
Day’s range139.01 - 141.29
Volume1,436,254
Average volume (3 months)1,908,615
Market cap$31.3B
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+20.84%
Earnings growth (next 5 years)+20.62%
Revenue growth (last year)+21.11%
P/E ratio60.8
Price/Sales9.22
Price/Book3.61

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.02+0.03%
BAXBaxter International...-0.37-0.58%
INCYIncyte Corp-0.87-0.76%
VRTXVertex Pharmaceutica...-0.16-0.10%
Data as of 4:01pm ET, 10/19/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.32
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts